Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation.
Hemorrhage
Iron
Mass spectrometry
Myocardial infarction
T2*
Journal
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616
Informations de publication
Date de publication:
30 09 2021
30 09 2021
Historique:
received:
30
01
2021
accepted:
23
05
2021
entrez:
30
9
2021
pubmed:
1
10
2021
medline:
4
11
2021
Statut:
epublish
Résumé
T2* cardiovascular magnetic resonance (CMR) is commonly used in the diagnosis of intramyocardial hemorrhage (IMH). For quantifying IMH with T2* CMR, despite the lack of consensus studies, two different methods [subject-specific T2* (ssT2*) and absolute T2* thresholding (aT2* < 20 ms)] are interchangeably used. We examined whether these approaches yield equivalent information. ST elevation myocardial infarction (STEMI) patients (n = 70) were prospectively recruited for CMR at 4-7 days post revascularization and for 6-month follow up (n = 43). Canines studies were performed for validation purposes, where animals (n = 20) were subject to reperfused myocardial infarction (MI) and those surviving the MI (n = 16) underwent CMR at 7 days and 8 weeks and then euthanized. Both in patients and animals, T2* of IMH and volume of IMH were determined using ssT2* and aT2* < 20 ms. In animals, ex-vivo T2* CMR and mass spectrometry for iron concentration ([Fe] While both approaches showed many similarities, there were also differences. Compared to ssT2*, aT2* < 20 ms showed lower T2* and volume of IMH in patients and animals independent of MI age (all p < 0.005). While T2* determined from both methods were highly correlated against [Fe] Current quantification methods have excellent capacity to identify IMH, albeit the T2*of IMH and volume of IMH based on aT2* < 20 ms are smaller compared to ssT2*. Thus the method used to quantify IMH from T2* CMR may influence the diagnosis for IMH.
Sections du résumé
BACKGROUND
T2* cardiovascular magnetic resonance (CMR) is commonly used in the diagnosis of intramyocardial hemorrhage (IMH). For quantifying IMH with T2* CMR, despite the lack of consensus studies, two different methods [subject-specific T2* (ssT2*) and absolute T2* thresholding (aT2* < 20 ms)] are interchangeably used. We examined whether these approaches yield equivalent information.
METHODS
ST elevation myocardial infarction (STEMI) patients (n = 70) were prospectively recruited for CMR at 4-7 days post revascularization and for 6-month follow up (n = 43). Canines studies were performed for validation purposes, where animals (n = 20) were subject to reperfused myocardial infarction (MI) and those surviving the MI (n = 16) underwent CMR at 7 days and 8 weeks and then euthanized. Both in patients and animals, T2* of IMH and volume of IMH were determined using ssT2* and aT2* < 20 ms. In animals, ex-vivo T2* CMR and mass spectrometry for iron concentration ([Fe]
RESULTS
While both approaches showed many similarities, there were also differences. Compared to ssT2*, aT2* < 20 ms showed lower T2* and volume of IMH in patients and animals independent of MI age (all p < 0.005). While T2* determined from both methods were highly correlated against [Fe]
CONCLUSION
Current quantification methods have excellent capacity to identify IMH, albeit the T2*of IMH and volume of IMH based on aT2* < 20 ms are smaller compared to ssT2*. Thus the method used to quantify IMH from T2* CMR may influence the diagnosis for IMH.
Identifiants
pubmed: 34587984
doi: 10.1186/s12968-021-00779-4
pii: 10.1186/s12968-021-00779-4
pmc: PMC8482734
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL133407
Pays : United States
Organisme : NIH HHS
ID : HL133407
Pays : United States
Organisme : NIH HHS
ID : HL136578
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s).
Références
Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI. J Am Coll Cardiol. 2016;67:1674–83.
doi: 10.1016/j.jacc.2016.01.069
Kendziora B, Dewey M. Prognostic value of the myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement magnetic resonance imaging after ST-segment elevation myocardial infarction: a systematic review and meta-regression analysis. PLoS ONE. 2020;15:0228736.
doi: 10.1371/journal.pone.0228736
Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–72.
doi: 10.1161/01.CIR.97.8.765
Eitel I, Kubusch K, Strohm O, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation–myocardial infarction. Circ Cardiovasc Imaging. 2011;4:354–62.
doi: 10.1161/CIRCIMAGING.110.960500
Ibanez B, Aletras AH, Arai AE, et al. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials. J Am Coll Cardiol. 2019;74:238–56.
doi: 10.1016/j.jacc.2019.05.024
Carrick D, Haig C, Ahmed N, et al. Myocardial hemorrhage after acute reperfused ST-segment–elevation myocardial infarction. Circ: Cardiovasc Imaging. 2016;9.
de Waha S, Patel MR, Granger CB, et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502–10.
doi: 10.1093/eurheartj/ehx414
Kali A, Kumar A, Cokic I, et al. Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging. 2013;6:218–28.
doi: 10.1161/CIRCIMAGING.112.000133
Kali A, Cokic I, Tang R, et al. Persistent microvascular obstruction after myocardial infarction culminates in the confluence of ferric iron oxide crystals, proinflammatory burden, and adverse remodeling. Circ: Cardiovasc Imaging. 2016;9.
Wang G, Yang H, Kali A, et al. Influence of myocardial hemorrhage on staging of reperfused myocardial infarctions with T2 cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2019;12:693–703.
doi: 10.1016/j.jcmg.2018.01.018
Cokic I, Kali A, Yang H, et al. Iron-sensitive cardiac magnetic resonance imaging for prediction of ventricular arrhythmia risk in patients with chronic myocardial infarction. Circ: Cardiovasc Imaging. 2015;8.
Carberry J, Carrick D, Haig C, et al. Persistent iron within the infarct core after ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging. 2018;11:1248–56.
doi: 10.1016/j.jcmg.2017.08.027
Husser O, Monmeneu JV, Sanchis J, et al. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Int J Cardiol. 2013;167:2047–54.
doi: 10.1016/j.ijcard.2012.05.055
Carrick D, Haig C, Ahmed N, et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST‐segment elevation myocardial infarction: pathophysiological insights and clinical implications. J Am Heart Assoc. 2016;5.
Kali A, Tang RL, Kumar A, Min JK, Dharmakumar R. Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging: T2 versus T2. Radiology. 2013;269:387–95.
doi: 10.1148/radiol.13122397
Kumar A, Green JD, Sykes JM, et al. Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging. 2011;4:1274–83.
doi: 10.1016/j.jcmg.2011.08.016
Alkhalil M, Borlotti A, De Maria GL, et al. Hyper-acute cardiovascular magnetic resonance T1 mapping predicts infarct characteristics in patients with ST elevation myocardial infarction. J Cardiovasc Magn R. 2020;22.
Anderson L. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.
doi: 10.1053/euhj.2001.2822
Moon BF, Iyer SK, Hwuang E, et al. Iron imaging in myocardial infarction reperfusion injury. Nat Commun. 2020;11.
Carpenter J, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28.
doi: 10.1161/CIRCULATIONAHA.110.007641
Bulluck HP, Hammond-Haley MM, Weinmann SM, Martinez-Macias RM, Hausenloy DJP. Myocardial infarct Size by CMR in clinical cardioprotection studies. JACC Cardiovasc Imaging. 2017;10:230–40.
doi: 10.1016/j.jcmg.2017.01.008
Diedenhofen B, Musch J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS ONE. 2015;10:0121945.
doi: 10.1371/journal.pone.0121945
Delong E, Delong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
doi: 10.2307/2531595
Triadyaksa P, Oudkerk M, Sijens PE. Cardiac T2 * mapping: techniques and clinical applications. J Magn Reson Imaging. 2020;52:1340–51.
doi: 10.1002/jmri.27023
Bradley WGJ. MR appearance of hemorrhage in the brain. Radiology. 1993;189:15–26.
doi: 10.1148/radiology.189.1.8372185
Carberry J, Carrick D, Haig C, et al. Persistent iron within the infarct core after ST-segment elevation myocardial infarction. JACC Cardiovascu Imaging. 2018;11:1248–56.
doi: 10.1016/j.jcmg.2017.08.027